Evidence map›Paper›PMID 24135719›Full record

ArticleDevelopmental and comparative immunology2014

Aedes aegypti ML and Niemann-Pick type C family members are agonists of dengue virus infection.

Natapong Jupatanakul, Shuzhen Sim, George Dimopoulos

Abstract read
In one paragraph

Article in Developmental and comparative immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Pathogen-inspired engineering of plant protease enhances late blight resistance.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Dietary Lipids and Their Metabolism in the Midgut.Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Review
  5. A myeloid differentiation-like protein in partnership with Toll5 from the pest insectProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Viruses · 2024
    Article
  8. Article
  9. Niemann-Pick Type C2 Proteins inInternational journal of molecular sciences · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. The buzz in the field: the interaction between viruses, mosquitoes, and metabolism.Frontiers in cellular and infection microbiology · 2023
    Review
  14. Transcriptional response ofThe Journal of general virology · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natapong JupatanakulW. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA.
Shuzhen SimW. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA.
George DimopoulosW. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA. Electronic address: gdimopou@jhsph.edu.

Funding

Targeting dengue in the mosquito with small moleculesR01AI101431 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DIMOPOULOS, GEORGE, ENGEL, DANIEL A · 2012 to 2016
$4.3M
Aedes anti-dengue immunityR01AI078997 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DIMOPOULOS, GEORGE · 2009 to 2010
$805k
Zika and dengue virus agonists for transmission-blockingR21AI136456 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DIMOPOULOS, GEORGE · 2018 to 2019
$450k
The JAK-STAT pathway in anti-dengue defenseR21AI090188 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DIMOPOULOS, GEORGE · 2010 to 2011
$448k
NIAID NIH HHS R01 AI078997NIAID NIH HHS R01 AI101431NIAID NIH HHS R01AI101431NIAID NIH HHS R21 AI090188NIAID NIH HHS R21 AI136456NIAID NIH HHS R R21AI090188
6 · The paper itself

Abstract

Upon exposure to dengue virus, the Aedes aegypti mosquito vector mounts an anti-viral immune defense by activating the Toll, JAK/STAT, and RNAi pathways, thereby limiting infection. While these pathways and several other factors have been identified as dengue virus antagonists, our knowledge of factors that facilitate dengue virus infection is limited. Previous dengue virus infection-responsive transcriptome analyses have revealed an increased mRNA abundance of members of the myeloid differentiation 2-related lipid recognition protein (ML) and the Niemann Pick-type C1 (NPC1) families upon dengue virus infection. These genes encode lipid-binding proteins that have been shown to play a role in host-pathogen interactions in other organisms. RNAi-mediated gene silencing of a ML and a NPC1 gene family member in both laboratory strain and field-derived Ae. aegypti mosquitoes resulted in significantly elevated resistance to dengue virus in mosquito midguts, suggesting that these genes play roles as dengue virus agonists. In addition to their possible roles in virus cell entry and replication, gene expression analyses suggested that ML and NPC1 family members also facilitate viral infection by modulating the mosquito's immune competence. Our study suggests that the dengue virus influences the expression of these genes to facilitate its infection of the mosquito host.

Indexed as

AedesAnimalsCarrier ProteinsCells, CulturedDensovirinaeGene Expression ProfilingHost-Pathogen InteractionsHumansImmunity, InnateInsect ProteinsLipid MetabolismLymphocyte Antigen 96Parvoviridae InfectionsProtein BindingReceptors, Pattern RecognitionRNA, Small InterferingCarrier ProteinsInsect ProteinsLY96 protein, humanLymphocyte Antigen 96Receptors, Pattern RecognitionRNA, Small InterferingAedes aegyptiDengue virusMyeloid differentiation 2-related lipid recognition geneNiemann Pick-type C gene

Identifiers

PMID24135719
PMCPMC3935818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.